Fondazione Istituto Neurologico Nazionale Casimiro Mondino

The Fondazione Istituto Neurologico Nazionale Casimiro Mondino in Pavia is conducting a broad range of studies in Nervous System Diseases, with a strong focus on Parkinson disease, multiple sclerosis, epilepsy, and migraine. These trials are designed to test new therapies, improve symptom control, and better understand how neurological conditions progress over time.

• Research in Parkinson disease and advanced motor symptoms, including treatments aimed at reducing fluctuations and improving daily function
• Studies in multiple sclerosis and related disorders, including efforts to slow disability progression and support relapse prevention
• Clinical trials in epilepsy and seizure disorders, focused on lowering seizure frequency and improving long-term seizure control
• Migraine research spanning prevention and acute treatment, with attention to both adult and pediatric patients

Overall, the site is active in evaluating new approaches that may offer better symptom relief, stronger disease control, and improved quality of life for people living with complex neurological conditions.

Clinical research at this site also covers Immune System Diseases, especially autoimmune conditions that affect the nervous system. Key areas include generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, neuromyelitis optica spectrum disorder, and other immune-mediated neurological diseases. The purpose of these studies is to evaluate whether new treatments can reduce immune-driven damage and improve neurological function.

• Generalized myasthenia gravis studies aimed at improving muscle strength and controlling disease activity
• Chronic inflammatory demyelinating polyneuropathy research focused on disability reduction and long-term symptom management
• Trials in neuromyelitis optica spectrum disorder and related autoimmune disorders to assess relapse prevention and disease stabilization
• Investigation of therapies for broader autoimmune encephalitis and antibody-mediated neurological conditions

These studies reflect a strong interest in targeted immune therapies that may offer more precise treatment options for patients with difficult-to-manage autoimmune diseases.

Within Psychiatry and Psychology, the site includes research on behavioral and neurodevelopmental conditions such as autism spectrum disorder and related irritability symptoms. The trials are generally aimed at improving behavioral outcomes, supporting day-to-day functioning, and evaluating the safety and usefulness of new treatment options in children and adolescents.

• Autism spectrum disorder studies addressing irritability and broader behavioral symptoms
• Pediatric research exploring whether new therapies can improve behavioral stability and quality of life
• Trials that examine longer-term treatment safety in younger populations with neurodevelopmental needs

This area adds an important child-focused dimension to the site’s broader neurological research portfolio.

Although the site is primarily known for neurology, it also participates in studies linked to Cardiovascular Diseases, including acute ischemic stroke, hypertension, and broader cardiovascular risk in people with neurological disease. These trials are designed to improve prevention, support recovery, and better manage conditions that can affect brain health and long-term outcomes.

• Acute ischemic stroke research focused on improving early treatment and recovery
• Hypertension and high-risk cardiovascular studies connected to disease prevention
• Investigations into vascular factors that may influence neurological disability and future complications

This work highlights the connection between vascular health and neurological care at the Fondazione Istituto Neurologico Nazionale Casimiro Mondino.

Research in Musculoskeletal Diseases at the site includes conditions that affect movement, posture, and muscle control, such as cervical dystonia and spinal muscular atrophy. The main goal of these trials is to test treatments that may ease motor symptoms, improve physical function, and support independence in everyday activities.

• Cervical dystonia studies evaluating symptom reduction and improved neck control
• Spinal muscular atrophy research focused on preserving motor ability and functional outcomes
• Trials exploring therapies that may help people with movement-related disability live more independently

These studies complement the site’s broader expertise in movement and neurological disorders.